LANTERN PHARMA INC's ticker is LTRN and the CUSIP is 51654W101. A total of 34 filers reported holding LANTERN PHARMA INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,332 | -52.0% | 1,857 | -20.6% | 0.00% | – |
| Q2 2023 | $13,192 | +131820.0% | 2,339 | +10.5% | 0.00% | – |
| Q1 2023 | $10 | – | 2,117 | +7460.7% | 0.00% | – |
| Q4 2022 | $0 | -100.0% | 28 | -99.3% | 0.00% | – |
| Q3 2022 | $19,000 | +216.7% | 3,817 | +238.7% | 0.00% | – |
| Q2 2022 | $6,000 | 0.0% | 1,127 | +45.8% | 0.00% | – |
| Q1 2022 | $6,000 | -53.8% | 773 | -52.0% | 0.00% | – |
| Q4 2021 | $13,000 | +116.7% | 1,612 | +204.2% | 0.00% | – |
| Q3 2021 | $6,000 | +20.0% | 530 | +50.6% | 0.00% | – |
| Q2 2021 | $5,000 | +400.0% | 352 | +467.7% | 0.00% | – |
| Q1 2021 | $1,000 | -90.9% | 62 | -89.5% | 0.00% | – |
| Q4 2020 | $11,000 | -15.4% | 593 | -16.4% | 0.00% | – |
| Q3 2020 | $13,000 | +550.0% | 709 | +317.1% | 0.00% | – |
| Q2 2020 | $2,000 | – | 170 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SANDERS MORRIS HARRIS LLC | 365,930 | $1,721,000 | 0.42% |
| CM Management, LLC | 50,000 | $239,000 | 0.27% |
| WOLFF WIESE MAGANA LLC | 30,462 | $146,000 | 0.12% |
| Redmond Asset Management, LLC | 49,502 | $237,000 | 0.09% |
| CARLSON CAPITAL L P | 168,000 | $803,000 | 0.06% |
| NewEdge Advisors, LLC | 171,019 | $817,000 | 0.01% |
| Sigma Planning Corp | 17,500 | $84,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 3,984 | $19,000 | 0.00% |
| NORTHERN TRUST CORP | 12,629 | $60,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |